South and Central America Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery



Summary



GlobalData’s new report, “South and Central America Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery” provides key market data on the South and Central America Diabetes Care Devices market – Brazil, Mexico and Argentina.. The report provides value (USD million) data for all the market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.



Scope


- Countries covered include Brazil, Mexico and Argentina..
- Market size and company share data for Diabetes Care Devices market categories – Insulin Delivery and Glucose Monitoring.
- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the market categories and countries.
- Global corporate-level profiles of key companies operating within the South and Central America Diabetes Care Devices market.
- Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Abbott Laboratories, Bayer HealthCare AG, Novo Nordisk A/S, Becton, Dickinson and Company, Sanofi, Eli Lilly and Company, Nipro Corporation and Arkray, Inc..



Reasons to buy


- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the South and Central America Diabetes Care Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Table Of Contents

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 What is This Report About? 7
3 Diabetes Care Devices in South and Central America 8
3.1 Diabetes Care Devices Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018 8
3.2 Diabetes Care Devices, South and Central America, Overall Revenue ($m), USD Constant, 2004-2018 9
3.3 Diabetes Care Devices, South and Central America, Company share (2010-2011) 15
4 Diabetes Care Devices In Argentina 17
4.1 Diabetes Care Devices, Argentina, Overall Revenue ($m), USD Constant, 2004-2018 17
4.2 Diabetes Care Devices, Argentina, Distribution Share (2010-2011) 22
4.2.1 Glucose Monitoring, Argentina, Distribution Share (2010-2011) 22
4.2.2 Insulin Delivery, Argentina, Distribution Share (2010-2011) 22
4.3 Diabetes Care Devices, Argentina, Company Share (2010-2011) 23
4.3.1 Diabetes Care Devices, Argentina, Company Share (2010-2011) 23
4.3.2 Glucose Monitoring, Argentina, Company Share (2010-2011) 25
4.3.3 Insulin Delivery, Argentina, Company Share (2010-2011) 27
5 Diabetes Care Devices In Brazil 29
5.1 Diabetes Care Devices, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 29
5.2 Diabetes Care Devices, Brazil, Distribution Share (2010-2011) 34
5.2.1 Glucose Monitoring, Brazil, Distribution Share (2010-2011) 34
5.2.2 Insulin Delivery, Brazil, Distribution Share (2010-2011) 34
5.3 Diabetes Care Devices, Brazil, Company Share (2010-2011) 35
5.3.1 Diabetes Care Devices, Brazil, Company Share (2010-2011) 35
5.3.2 Diabetes Care Devices, Brazil, Company Share (2010-2011) 37
5.3.3 Insulin Delivery, Brazil, Company Share (2010-2011) 39
6 Diabetes Care Devices In Mexico 41
6.1 Diabetes Care Devices, Mexico, Overall Revenue ($m), USD Constant, 2004-2018 41
6.2 Diabetes Care Devices, Mexico, Distribution Share (2010-2011) 46
6.2.1 Glucose Monitoring, Mexico, Distribution Share (2010-2011) 46
6.2.2 Insulin Delivery, Mexico, Distribution Share (2010-2011) 46
6.3 Diabetes Care Devices, Mexico, Company Share (2010-2011) 47
6.3.1 Diabetes Care Devices, Mexico, Company Share (2010-2011) 47
6.3.2 Glucose Monitoring, Mexico, Company Share (2010-2011) 49
6.3.3 Insulin Delivery, Mexico, Company Share (2010-2011) 51
7 Overview of Key Companies in South and Central America Diabetes Care Devices Market 53
7.1 F. Hoffmann-La Roche Ltd. 53
7.1.1 Company Overview 53
7.1.2 Share in the South and Central America Diabetes Care Devices Market 53
7.2 LifeScan, Inc. 54
7.2.1 Company Overview 54
7.2.2 Share in the South and Central America Diabetes Care Devices Market 54
7.3 Abbott Laboratories 55
7.3.1 Company Overview 55
7.3.2 Share in the South and Central America Diabetes Care Devices Market 55
7.4 Bayer HealthCare AG 56
7.4.1 Company Overview 56
7.4.2 Share in the South and Central America Diabetes Care Devices Market 56
7.5 Novo Nordisk A/S 57
7.5.1 Company Overview 57
7.5.2 Share in the South and Central America Diabetes Care Devices Market 57
7.6 Becton, Dickinson and Company 58
7.6.1 Company Overview 58
7.6.2 Share in the South and Central America Diabetes Care Devices Market 58
7.7 Sanofi 59
7.7.1 Company Overview 59
7.8 Eli Lilly and Company 59
7.8.1 Company Overview 59
7.9 Nipro Corporation 60
7.9.1 Company Overview 60
7.10 Arkray, Inc. 60
7.10.1 Company Overview 60
7.11 Medtronic, Inc. 60
7.11.1 Company Overview 60
8 Diabetes Care Devices Market Pipeline Products 61
9 Appendix 64
9.1 Definitions of Markets Covered in the Report 65
9.1.1 Diabetes Care Devices 65
9.2 Research Methodology 66
9.3 Secondary Research 66
9.4 Primary Research 67
9.5 Models 67
9.6 Forecasts 68
9.7 Expert Panels 68
9.8 GlobalData Consulting 68
9.9 Currency Conversion 69
9.10 Contact Us 69
9.11 Disclaimer 69

1.1 List of Tables

Table 1: Diabetes Care Devices, Cross Country Comparison, Revenue ($m),USD Constant, 2004-2018 8
Table 2: Diabetes Care Devices, South and Central America, Overall Revenue ($m), USD Constant, 2004-2018 10
Table 3: Diabetes Care Devices, South and Central America, Overall Revenue ($m), USD Constant, Historic, 2004-2011 12
Table 4: Diabetes Care Devices, South and Central America, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 14
Table 5: Diabetes Care Devices, South and Central America, Company share by Revenue ($m), USD Constant, 2010-2011 16
Table 6: Diabetes Care Devices, Argentina, Overall Revenue ($m), USD Constant, 2004-2018 17
Table 7: Diabetes Care Devices, Argentina, Overall Revenue ($m), USD Constant, Historic, 2004-2011 19
Table 8: Diabetes Care Devices, Argentina, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 21
Table 9: Glucose Monitoring, Argentina, Distribution Share by Revenue ($m), USD Constant, 2010-2011 22
Table 10: Insulin Delivery, Argentina, Distribution Share by Revenue ($m), USD Constant, 2010-2011 22
Table 11: Diabetes Care Devices, Argentina, Company Share by Revenue ($m), USD Constant, 2010-2011 24
Table 12: Glucose Monitoring, Argentina, Company Share by Revenue ($m), USD Constant, 2010-2011 26
Table 13: Insulin Delivery, Argentina, Company Share by Revenue ($m), USD Constant, 2010-2011 28
Table 14: Diabetes Care Devices, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 29
Table 15: Diabetes Care Devices, Brazil, Overall Revenue ($m), USD Constant, Historic, 2004-2011 31
Table 16: Diabetes Care Devices, Brazil, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 33
Table 17: Glucose Monitoring, Brazil, Distribution Share by Revenue ($m), USD Constant, 2010-2011 34
Table 18: Insulin Delivery, Brazil, Distribution Share by Revenue ($m), USD Constant, 2010-2011 34
Table 19: Diabetes Care Devices, Brazil, Company Share, USD Constant, (2010-2011) 36
Table 20: Glucose Monitoring, Brazil, Company Share by Revenue ($m), USD Constant, 2010-2011 38
Table 21: Insulin Delivery, Brazil, Company Share by Revenue ($m), USD Constant, 2010-2011 40
Table 22: Diabetes Care Devices, Mexico, Overall Revenue ($m), USD Constant, 2004-2018 41
Table 23: Diabetes Care Devices, Mexico, Overall Revenue ($m), USD Constant, Historic, 2004-2011 43
Table 24: Diabetes Care Devices, Mexico, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 45
Table 25: Glucose Monitoring, Mexico, Distribution Share by Revenue ($m), USD Constant, 2010-2011 46
Table 26: Insulin Delivery, Mexico, Distribution Share by Revenue ($m), USD Constant, 2010-2011 46
Table 27: Diabetes Care Devices, Mexico, Company Share by Revenue ($m), USD Constant, 2010-2011 48
Table 28: Glucose Monitoring, Mexico, Company Share by Revenue ($m), USD Constant, 2010-2011 50
Table 29: Insulin Delivery, Mexico, Company Share by Revenue ($m), USD Constant, 2010-2011 52
Table 30: Diabetes Care DevicesMarket Pipeline Products 61

1.2 List of Figures

Figure 1: Diabetes Care Devices, Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018 8
Figure 2: Diabetes Care Devices, South and Central America, Overall Revenue ($m), USD Constant, 2004-2018 9
Figure 3: Diabetes Care Devices, South and Central America, Overall Revenue ($m), USD Constant, Historic, 2004-2011 11
Figure 4: Diabetes Care Devices, South and Central America, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 13
Figure 5: Diabetes Care Devices, South and Central America, Company share (%), 2011 15
Figure 6: Diabetes Care Devices, Argentina, Overall Revenue ($m), USD Constant, 2004-2018 17
Figure 7: Diabetes Care Devices, Argentina, Overall Revenue ($m), USD Constant, Historic, 2004-2011 18
Figure 8: Diabetes Care Devices, Argentina, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 20
Figure 9: Diabetes Care Devices, Argentina, Company Share (%), 2011 23
Figure 10: Glucose Monitoring, Argentina, Company Share (%), 2011 25
Figure 11: Insulin Delivery, Argentina, Company Share (%), 2011 27
Figure 12: Diabetes Care Devices, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 29
Figure 13: Diabetes Care Devices, Brazil, Overall Revenue ($m), USD Constant, Historic, 2004-2011 30
Figure 14: Diabetes Care Devices, Brazil, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 32
Figure 15: Diabetes Care Devices, Brazil, Company Share (%), 2011 35
Figure 16: Diabetes Care Devices, Brazil, Company Share (%), 2011 37
Figure 17: Insulin Delivery, Brazil, Company Share (%), 2011 39
Figure 18: Diabetes Care Devices, Mexico, Overall Revenue ($m), USD Constant, 2004-2018 41
Figure 19: Diabetes Care Devices, Mexico, Overall Revenue ($m), USD Constant, Historic, 2004-2011 42
Figure 20: Diabetes Care Devices, Mexico, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 44
Figure 21: Diabetes Care Devices, Mexico, Company Share (%), 2011 47
Figure 22: Glucose Monitoring, Mexico, Company Share (%), 2011 49
Figure 23: Insulin Delivery, Mexico, Company Share (%), 2011 51
Figure 24: F. Hoffmann-La Roche Ltd., Company Share (%), South and Central America Diabetes Care Devices Market, 2011 53
Figure 25: LifeScan, Inc., Company Share (%), South and Central America Diabetes Care Devices Market, 2011 54
Figure 26: Abbott Laboratories, Company Share (%), South and Central America Diabetes Care Devices Market, 2011 55
Figure 27: Bayer HealthCare AG, Company Share (%), South and Central America Diabetes Care Devices Market, 2011 56
Figure 28: Novo Nordisk A/S, Company Share (%), South and Central America Diabetes Care Devices Market, 2011 57
Figure 29: Becton, Dickinson and Company, Company Share (%), South and Central America Diabetes Care Devices Market, 2011 58

Companies mentioned
F. Hoffmann-La Roche Ltd.
LifeScan, Inc.
Abbott Laboratories
Bayer HealthCare AG
Novo Nordisk A/S
Becton, Dickinson and Company
Sanofi
Eli Lilly and Company
Nipro Corporation
Arkray, Inc.
Medtronic, Inc.

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Parkinson's Disease - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Parkinson's Disease - Global Drug Forecast and Market Analysis to 2022

  • $ 9 995
  • Industry report
  • March 2014
  • by Global Data

PharmaPoint: Parkinson's Disease - Global Drug Forecast and Market Analysis to 2022 Summary Parkinson's disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, ...

PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

  • $ 9 995
  • Industry report
  • April 2014
  • by Global Data

PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update Summary Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most ...

Analytical Tool - Hematological Cancers

Analytical Tool - Hematological Cancers

  • $ 8 925
  • Industry report
  • March 2014
  • by Bioseeker

"Analytical Tool - Hematological Cancers" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in hematological cancers. It is ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.